SCOLR Pharma, Inc.
Common Stocks and Warrants ~ March 2010
SCOLR Pharma, Inc. (NYSE AMEX: DDD) is a specialty pharmaceutical company developing novel prescription pharmaceutical, OTC, and nutritional products based on its patented CDT platform (controlled delivery technology). SCOLR’s CDT drug delivery platforms offer better oral drug delivery alternatives to existing methods. Using standard manufacturing equipment and GRAS ingredients, CDT is less complex, more cost-effective and applicable to a wide range of programmed releases or enhanced performance of active pharmaceutical ingredients and nutritional products.
When SCOLR needed equity capital to support the implementation of its business strategy from its new CEO, it turned to Taglich Brothers. We helped deliver the capital necessary for the Company to pursue increased direct sales of nutritional products and aggressively seek licensing deals to expand its capabilities.
The information contained herein does not constitute a solicitation of any order to buy or sell any securities. The information provided herein may be displayed and printed for your personal, noncommercial use only. You may not reproduce, retransmit, distribute, disseminate, sell, publish, broadcast or circulate the information to anyone, without the express written consent of Taglich Brothers, Inc.